Abstract Theiler's murine encephalomyelitis virus is a widely used model to study the initiation and progression of multiple sclerosis. Many researchers have used this model to investigate how the immune system and genetic factors contribute to the disease process. Current research has highlighted the importance of cytotoxic CD8 T cells and specific major histocompatibility complex (MHC) class I alleles. Our lab has adopted this concept to create a novel mouse model to study the mechanism of blood-brain barrier (BBB) disruption, an integral feature of numerous neurological disorders. We have demonstrated that epitope-specific CD8 T cells cause disruption of the tight junction architecture and ensuing CNS vascular permeability in the absence of neutrophil support. This CD8 T cell-initiated BBB disruption is dependent on perforin expression. We have also elucidated a potential role for hematopoietic factors in this process. Despite having identical MHC class I molecules, similar inflammation in the CNS, and equivalent ability to utilize perforin, C57BL/6 mice are highly susceptible to this condition, while 129 SvIm mice are resistant. This susceptibility is transferable with the bone marrow compartment. These findings led us to conduct a comprehensive genetic analysis which has revealed a list of candidate genes implicated in regulating traits associated with BBB disruption. Future studies will continue to define the underlying molecular mechanism of CD8 T cell-initiated BBB disruption and may assist in the development of potential therapeutic approaches to ameliorate pathology associated with BBB disruption in neurological disorders.
Introduction
Theiler's murine encephalomyelitis virus (TMEV) is a small RNA picornavirus commonly used to study multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system (CNS). Intracerebral injection of the Daniel's strain of TMEV produces a transient early meningoencephalitis in all mouse strains, while causing persistent infection of the white matter accompanied by demyelination in susceptible strains (Njenga et al. 1997; Rodriguez and David 1985; Rodriguez et al. 1986 ). Since environmental agents such as viral infections have been associated with MS and infection with TMEV induces pathology similar to human MS, numerous researchers have adopted this model in an attempt to elucidate the mechanisms of disease initiation and progression and to develop potential therapeutic approaches to treat this disease (Denic et al. 2011 ). The TMEV model may also help us better understand the pathogenesis of additional diseases, such as those induced by Saffold virus, a human Cardiovirus grouped with TMEV that may be involved in respiratory illnesses, GI illnesses, and type I diabetes in addition to neurological diseases (Himeda and Ohara 2012) .
TMEV as a model system to study CD8 T cells in MS
It has been shown that CD8 T cells are the predominant lymphocyte present in active MS lesions (Babbe et al. 2000) . Therefore, many researchers have employed the TMEV model to investigate how CD8 T cells contribute to pathology associated with MS. One proposed mechanism of action is that TMEV induces autoreactive cytotoxic CD8 T cells resulting in CNS pathology including spinal cord lesions (Tsunoda et al. 2002; Tsunoda et al. 2005) . Other studies have focused on the role of specific major histocompatibility complex (MHC) class I alleles, which present peptide antigens to cytotoxic T lymphocytes (CTLs), in the pathogenesis of disease. Resistant C57BL/6 mice have been shown to clear viral infection by mounting a virus-specific CTL response that is highly focused on an immunodominant TMEV peptide, VP2 [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] , presented in the context of the D b class I molecule (Johnson et al. 1999; Johnson et al. 2001) . Interestingly, SJL/J mice, which are highly susceptible to TMEV infection, have also been shown to mount a fully functional virus-specific CTL response, producing IFN-γ and exhibiting the capability to lyse target cells. However, this response is largely restricted by the H-2K s molecule and is ineffective at clearing virus infection (Kang et al. 2002) . Furthermore, an analysis of (C57BL/6 × SJL/J) F1 progeny demonstrated that these mice showed a preference for an H-2D b -restricted CD8 T cell response and acquired resistance to TMEV infection (Jin et al. 2011) (Table 1) .
To further understand the role of epitope-specific CD8 T cells in contributing to neurological deficits associated with MS, another study inhibited D 130 epitope-specific CD8 T cell responses, but unlike C57BL/6 mice, they are highly susceptible to TMEV infection (Table 1) . Elimination of epitope-specific CD8 T cells from these mice resulted in preserved functional motor ability despite a slight trend towards a higher viral load (Johnson et al. 2001 ). Another recent study analyzed the role of epitope-specific CD8 T cells in promoting T1 black hole formation, which is visible as hypointense lesions on T1-weighted MRI scans. T1 black holes are a feature of human MS that is also observed in the TMEV model. Transfer of CD8 T cells into RAG1 −/− mice resulted in average T1 black hole volume. However, depletion of epitope-specific CD8 T cells resulted in reduced T1 hypointensities, further supporting a role for epitope-specific CD8 T cells in the formation of T1 black holes and thus in pathology associated with human MS . In summary, virus-specific CD8 T cells serve a dual purpose in that they can provide protection from TMEV-induced demyelinating diseases or directly contribute to neuropathogenesis.
The peptide-induced fatal syndrome model of CD8 T cellinitiated BBB disruption
In addition to playing a role in demyelinating diseases, CD8 T cells have also been implicated in disruption of the BBB. Our laboratory has employed a variation of TMEV infection to develop a novel mouse model of CNS vascular permeability, which is characteristic of numerous neurologic disorders, including dengue hemorrhagic fever, cerebral malaria, stroke, and acute hemorrhagic leukoencephalitis in addition to MS (Brown et al. 1999; Huber et al. 2001; LacerdaQueiroz et al. 2012; Medana and Turner 2006; Minagar and Alexander 2003; Nacer et al. 2012; Pirko et al. 2008; Talavera et al. 2004) . As described in the previous section, C57BL/6 mice respond to intracranial TMEV infection by mounting an antiviral CD8 T cell response that is highly focused on an immunodominant TMEV peptide, VP2 [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] , presented in the context of the D b class I molecule (Johnson et al. 1999; Johnson et al. 2001) (Fig. 1a) . Intravenous injection of VP2 121-130 peptide 7 days post-TMEV infection, during the peak of D b :VP2 121-130 epitope-specific CD8 T cell expansion, results in severe CNS vascular permeability followed by death within 48 h (Fig. 1b) . We have determined that this death is antigen-specific because TMEV-infected animals treated with mock E7 peptide remained asymptomatic (Johnson et al. 2005; Pirko et al. 2008 ). This difference is illustrated by confocal microscopic images, which show that VP2 121-130 -treated C57BL/6 mice exhibit degradation of the tight junction proteins claudin-5 and occludin in areas of FITC-albumin leakage compared to the preserved vascular integrity and intact tight junctions observed in E7-treated C57BL/6 mice ( Fig. 1c, d ). The extensive CNS vascular permeability in C57BL/6 mice treated with VP2 121-130 peptide is also illustrated by 3D gadolinium- Characterization of mouse strains according to whether they develop persistent TMEV infection, their CD8 T cell-restricted responses to specific major epitope(s), and their susceptibility to our PIFS model of CD8 T cell-initiated BBB disruption enhanced T1-weighted MRI scans (Fig. 1e, f) . We have therefore termed this condition as peptide-induced fatal syndrome (PIFS). This inducible model system of BBB disruption enables a kinetic analysis of early and late cellular and gene expression events, making it an ideal system to investigate CD8 T cellinitiated BBB disruption, a hallmark feature of numerous neurological conditions.
Molecular mechanisms in PIFS
Previous work done in our laboratory has highlighted the importance of CD8 T cells, perforin, and vascular endothelial growth factor (VEGF) in the PIFS model (Johnson et al. 2005; Suidan et al. 2010; Suidan et al. 2012; Suidan et al. 2008) . We have also demonstrated that other factors implicated in promoting BBB disruption, such as CD4 T cells, TNF-α, IFN-γ, LTβR, and IL-1, do not play a role in lethality in this model system (Johnson et al. 2005) . Due to the inducible nature of the PIFS model, we have also been able to determine the sequence of events that occur in the development of PIFS. We have demonstrated that astrocyte activation, as measured by glial fibrillary acidic protein expression, and alterations of the tight junction proteins claudin-5 and occludin occur prior to peak levels of CNS vascular permeability and functional motor [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] peptide or mock E7 peptide are intravenously administered on day 7, during the peak of CD8 T cell expansion. MRI is performed on the following day, and then the CNS is harvested for additional assays. c Confocal microscopic images illustrate that mice treated with mock E7 peptide have intact tight junction proteins and preserved vascular integrity. d
However, treatment with VP2 121-130 peptide results in disruption of the tight junction proteins claudin-5 and occludin in areas of FITCalbumin leakage, indicative of CNS vascular permeability. Gadoliniumenhanced T1-weighted MRI images illustrate the extent of CNS vascular permeability after e administration of mock E7 peptide and f administration of VP2 121-130 peptide to induce PIFS. 3D transparency rendering of gadolinium-enhancing areas are shown next to raw gadolinium-enhanced T1-weighted scans. f Treatment with VP2 121-130 peptide results in extensive CNS vascular permeability when compared to e treatment with mock E7 peptide deficits. It was also found that expression of perforin is essential for these processes to occur, as mice deficient in perforin exhibited negligible astrocyte activation, normal tight junction protein expression, and an absence of CNS vascular permeability .
Dissecting the underlying molecular mechanisms of immune-mediated fatal BBB disruption is of critical importance for the development of therapeutic strategies to treat neurological disorders characterized by extensive BBB disruption. One potential mechanism is induction of VEGF in the CNS. Time course experiments have enabled us to demonstrate that VEGF expression is significantly upregulated prior to and during peak levels of CNS vascular permeability. Inhibition of neuropilin-1, a VEGF coreceptor, resulted in a significant reduction in CNS vascular permeability, preservation of occludin protein levels, decreased microhemorrhage formation, and enhanced survival in C57BL/6 mice induced to undergo PIFS (Suidan et al. 2010; Suidan et al. 2012) . Furthermore, in situ hybridization and confocal microscopy demonstrate that neurons are the major source of VEGF expression (Suidan et al. 2010) . We have also shown that neurons are the primary cell type infected by TMEV, and that CD8 T cells actively engage these TMEV-infected neurons . Together, these findings elucidate a potential mechanism of BBB disruption, in which CD8 T cells interact with neurons to cause upregulation of VEGF, resulting in disruption of tight junction proteins and ensuing CNS vascular permeability (Fig. 2, pathway 1) .
Evidence for other cell types involved in BBB disruption
It remains possible that other immune cell types in addition to CD8 T cells may also contribute to BBB disruption (Fig. 2 , pathways 2 and 4). Previous studies have implicated neutrophils as being one such critical cell type, proposing that CD8 T cells attract this effector population to induce BBB disruption. This finding was demonstrated through the use of anti-GR-1 monoclonal antibody (mAb) RB6-8C5 to deplete neutrophils in vivo (Kim et al. 2009 ). This method of neutrophil depletion has been widely used to investigate the role of neutrophils in several disease processes, including cancer, cerebral malaria, and viral-induced encephalitis (Breitbach et al. 2007; Chen et al. 2000; Kim et al. 2009; Tazawa et al. 2003; Zhou et al. 2003) . However, this method has been shown to be nonspecific for neutrophils, since RB6-8C5 binds to both Ly-6G on neutrophils and Ly-6C on lymphocytes and monocytes (Daley et al. 2008; Dunay et al. 2010) . Using flow cytometric analysis, we demonstrated that CNSinfiltrating CD8 T cells are GR-1+. We also determined that treatment with anti-GR-1 mAb RB6-8C5 caused a significant reduction in CNS-infiltrating CD8 T cells in addition to GR-1+ cells when compared to treatment with anti-Ly6G mAb 1A8 or treatment with normal rat serum. We then investigated the effect of these depletion strategies on the tight junction architecture, CNS vascular permeability, and functional motor deficits in our PIFS model system. We discovered that specific depletion of neutrophils with anti- Fig. 2 Proposed mechanism of CD8 T cell-initiated BBB disruption based on summarized results acquired using the PIFS model system. Our primary hypothesis is that (1) CD8 T cells engage neurons to cause upregulation of VEGF, promoting disruption of the tight junction architecture, and ensuing CNS vascular permeability. Alternatively, it is possible that (2) CD8 T cells engage a different immune or CNS cell type, which may either cause upregulation of VEGF and directly lead to BBB disruption or (4) interact with neurons to increase VEGF, resulting in subsequent BBB disruption. It is also possible that (3) CD8 T cells directly engage cerebral endothelial cells to cause disruption of the tight junction proteins and ensuing CNS vascular permeability Ly6G mAb 1A8 still resulted in disruption of tight junction proteins occludin and claudin-5, severe CNS vascular permeability as revealed by 3D volumetric analysis of gadoliniumenhanced T1-weighted MRI images, and a significant decline in functional motor ability when compared to nonspecific depletion with anti-GR-1 mAb RB6-8C5 (Johnson et al. 2012a ). While neutrophils have been shown to be associated with vascular leakage in other viral models, these findings using our system of CD8 T cell-initiated BBB disruption support a role for CD8 T cells to cause disruption of the tight junction architecture, severe CNS vascular permeability, and functional motor deficits in the absence of neutrophil support. Therefore, CD8 T cells remain a prime target for potential therapeutic strategies to treat disorders characterized by BBB disruption.
Role of hematopoietic factors in PIFS
In addition to immune cells, a role for hematopoietic factors in contributing to the mechanism of BBB disruption is also important to investigate, since there is a relative lack of knowledge in this area. We have observed a difference in susceptibility to PIFS in C57BL/6 and 129 SvIm mouse strains, despite these strains having identical MHC class I molecules, similar levels of VP2 121-130 epitope-specific CNS-infiltrating CD8 T cells, and equivalent perforinmediated killing. C57BL/6 mice displayed higher levels of astrocyte activation, severe CNS vascular permeability, increased microhemorrhage formation, and functional motor deficits compared to 129 SvIm mice. Therefore, we hypothesized that hematopoietic factors contribute to the characteristics associated with PIFS. In order to investigate this, we performed bone marrow transplants by reconstituting lethally irradiated 129 SvIm mice with either C57BL/6 bone marrow or autologous bone marrow. We discovered that 129 SvIm mice receiving C57BL/6 bone marrow now became susceptible to PIFS. This was illustrated by an increase in microhemorrhage formation, extensive CNS vascular permeability, and functional motor deficits when compared to 129 SvIm mice receiving autologous bone marrow transfer. Therefore, since susceptibility to PIFS is transferable with the bone marrow compartment, there is a potential role for hematopoietic factors in contributing to traits characteristic of immune-mediated fatal BBB disruption (Johnson et al. 2012b ). It will be necessary to identify these hematopoietic factors to open up potential therapeutic interventions. Since the list of these potential factors is relatively extensive, our lab has recently performed a comprehensive genetic analysis of (C57BL/6 × 129 SvIm) F2 progeny, which we have observed to display variable susceptibility to PIFS. This analysis has allowed us to identify quantitative trait loci on chromosomes 12 and 17 linked to functional motor deficit and CNS vascular permeability, respectively. These findings have resulted in a list of potential candidate genes implicated in regulating these traits, opening up future avenues of research to dissect the underlying molecular mechanisms of BBB disruption.
Conclusion
Our lab has used a variation of the TMEV model to develop a novel inducible model of CNS vascular permeability in order to elucidate the mechanism of BBB disruption in neurological diseases. Prior to the studies described above, there was a relative lack of knowledge regarding the extent inflammatory immune cells and hematopoietic factors contributed to BBB disruption. Research conducted in our lab has begun to shed light on these mechanisms. One potential mechanism is that CD8 T cells engage neurons, causing upregulation of VEGF and subsequent degradation of the tight junction architecture and CNS vascular permeability (Fig. 2, pathway  1 ). Alternatively, it is possible that CD8 T cells may engage another immune or CNS cell type, causing an increase in VEGF, and leading to BBB disruption. This mechanism may be dependent or independent of engagement with neurons ( Fig. 2, pathways 2 and 4) . Furthermore, it is also possible that CD8 T cells directly engage cerebral endothelial cells to cause disruption of the tight junction proteins and ensuing CNS vascular permeability (Fig. 2, pathway 3) . Future research will continue to define the mechanism of BBB disruption by analyzing the interaction of CD8 T cells with specific CNS cell types. We have chosen to focus on the CNS because we have previously shown through gadoliniumenhanced T1-weighted MRI scans that CD8 T cell-mediated vascular permeability is specific to the CNS and is not observed in peripheral organs (Suidan et al. 2010) . Knowledge of the underlying mechanism of BBB disruption will be essential in the development of novel therapeutic approaches to ameliorate pathology associated with BBB disruption in neurological diseases.
